Q1 2026 Holdings
Filed 2026-05-15 | 49 holdings | $3.5B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Abivax SA American Depositary Shares(ABVX) | ADRS | 00370M103 | $721.7M | 6,481,085 | 20.6% |
| CG Oncology Inc(CGON) | COMM | 156944100 | $248.4M | 3,670,206 | 7.1% |
| Tango Therapeutics Inc(TNGX) | COMM | 87583X109 | $220.3M | 10,531,071 | 6.3% |
| Cogent Biosciences Inc(COGT) | COMM | 19240Q201 | $190.4M | 4,946,894 | 5.4% |
| Centessa Pharmaceuticals PLC(CNTA) | ADRS | 152309100 | $170.3M | 4,286,480 | 4.9% |
| Dianthus Therapeutics Inc(DNTH) | COMM | 252828108 | $140.7M | 1,676,624 | 4.0% |
| Tyra Biosciences Inc(TYRA) | COMM | 90240B106 | $124.4M | 3,248,980 | 3.6% |
| Immunovant Inc(IMVT) | COMM | 45258J102 | $110.7M | 4,457,988 | 3.2% |
| Biocryst Pharmaceuticals Inc(BCRX) | COMM | 09058V103 | $104.9M | 11,020,968 | 3.0% |
| Mirum Pharmaceuticals Inc(MIRM) | COMM | 604749101 | $98.1M | 1,062,049 | 2.8% |
| VOR Biopharma Inc(VOR) | COMM | 929033207 | $96.5M | 5,673,078 | 2.8% |
| Spyre Therapeutics Inc(SYRE) | COMM | 00773J202 | $95.9M | 1,900,582 | 2.7% |
| Amylyx Pharmaceuticals Inc(AMLX) | COMM | 03237H101 | $86.8M | 6,243,812 | 2.5% |
| Disc Medicine Inc(IRON) | COMM | 254604101 | $85.8M | 1,341,862 | 2.5% |
| Dyne Therapeutics Inc(DYN) | COMM | 26818M108 | $83.7M | 4,615,144 | 2.4% |
| Monte Rosa Therapeutics Inc(GLUE) | COMM | 61225M102 | $76.0M | 4,622,151 | 2.2% |
| Savara Inc(SVRA) | COMM | 805111101 | $67.5M | 12,362,205 | 1.9% |
| Revolution Medicines Inc(RVMD) | COMM | 76155X100 | $56.1M | 576,473 | 1.6% |
| Kodiak Sciences Inc(KOD) | COMM | 50015M109 | $55.1M | 1,445,538 | 1.6% |
| LB Pharmaceuticals Inc(LBRX) | COMM | 50180M108 | $45.3M | 1,839,489 | 1.3% |
| Surrozen Inc(SRZN) | COMM | 86889P208 | $42.9M | 1,473,101 | 1.2% |
| ADC Therapeutics SA(ADCT) | COMM | H0036K147 | $42.7M | 11,390,175 | 1.2% |
| Relay Therapeutics Inc(RLAY) | COMM | 75943R102 | $42.5M | 4,273,356 | 1.2% |
| Fulcrum Therapeutics Inc(FULC) | COMM | 359616109 | $40.3M | 5,250,000 | 1.2% |
| Biohaven LTD(BHVN) | COMM | G1110E107 | $39.2M | 4,631,317 | 1.1% |
| Century Therapeutics Inc(IPSC) | COMM | 15673T100 | $39.0M | 17,754,430 | 1.1% |
| Tectonic Therapeutic Inc(TECX) | COMM | 878972108 | $37.2M | 1,204,891 | 1.1% |
| Perspective Therapeutics Inc(CATX) | COMM | 46489V302 | $33.0M | 7,915,567 | 0.9% |
| Xencor Inc(XNCR) | COMM | 98401F105 | $29.6M | 2,452,138 | 0.8% |
| Entrada Therapeutics Inc(TRDA) | COMM | 29384C108 | $28.9M | 2,287,500 | 0.8% |
| ALX Oncology Holdings Inc(ALXO) | COMM | 00166B105 | $26.1M | 13,011,849 | 0.7% |
| Arvinas Holding Co LLC(ARVN) | COMM | 04335A105 | $25.3M | 2,387,461 | 0.7% |
| Janux Therapeutics Inc(JANX) | COMM | 47103J105 | $24.9M | 1,789,617 | 0.7% |
| Agomab Therapeutics NV(AGMB) | ADRS | 00860C102 | $21.5M | 2,053,233 | 0.6% |
| Alector Inc(ALEC) | COMM | 014442107 | $21.5M | 10,000,000 | 0.6% |
| MBX Biosciences Inc(MBX) | COMM | 55287L101 | $19.4M | 650,000 | 0.6% |
| Silence Therapeutics PLC(SLN) | ADRS | 82686Q101 | $16.0M | 3,033,560 | 0.5% |
| Liquidia Technologies Inc(LQDA) | COMM | 53635D202 | $15.2M | 403,048 | 0.4% |
| Ocular Therapeutix Inc(OCUL) | COMM | 67576A100 | $14.0M | 1,647,752 | 0.4% |
| Avalo Therapeutics Inc(AVTX) | COMM | 05338F306 | $11.0M | 738,383 | 0.3% |
| Urogen Pharma LTD(URGN) | COMM | M96088105 | $7.3M | 405,365 | 0.2% |
| Monopar Therapeutics Inc(MNPR) | COMM | 61023L207 | $7.2M | 132,103 | 0.2% |
| Context Therapeutics Inc(CNTX) | COMM | 21077P108 | $7.0M | 2,682,696 | 0.2% |
| Structure Therapeutics Inc(GPCR) | ADRS | 86366E106 | $6.8M | 140,411 | 0.2% |
| Cullinan Therapeutics Inc(CGEM) | COMM | 230031106 | $5.8M | 406,786 | 0.2% |
| Korro BIO Inc(KRRO) | COMM | 500946108 | $4.7M | 416,301 | 0.1% |
| Leonabio Inc(LONA) | COMM | 04746L203 | $4.7M | 464,398 | 0.1% |
| Upstream BIO Inc(UPB) | COMM | 91678A107 | $1.6M | 181,063 | 0.0% |
| Vistagen Therapeutics Inc(VTGN) | COMM | 92840H400 | $1.5M | 2,676,580 | 0.0% |